Safety and efficacy of alefacept in elderly patients and other special populations
Contributeurs/tricesGottlieb, Alice B.; Boehncke, Wolf-Henning; Darif, Mohamed
Publié dansJournal of drugs in dermatology, vol. 4, no. 6, p. 718-724
Date de publication2005
Résumé
Mots-clés
- Age Factors
- Aged
- Cholelithiasis/epidemiology
- Chronic Disease
- Comorbidity
- Dermatologic Agents/administration & dosage/adverse effects/*therapeutic use
- Diabetes Mellitus/epidemiology
- Drug Administration Schedule
- Humans
- Injections, Intramuscular
- Injections, Intravenous
- Multicenter Studies as Topic
- Obesity/epidemiology
- Psoriasis/drug therapy
- Randomized Controlled Trials as Topic
- Recombinant Fusion Proteins/administration & dosage/adverse effects/*therapeutic
- use
- Severity of Illness Index
- Time Factors
- Treatment Outcome
Structure d'affiliation Pas une publication de l'UNIGE
Citation (format ISO)
GOTTLIEB, Alice B., BOEHNCKE, Wolf-Henning, DARIF, Mohamed. Safety and efficacy of alefacept in elderly patients and other special populations. In: Journal of drugs in dermatology, 2005, vol. 4, n° 6, p. 718–724.